ABSTRACT
Sickle cell anemia (SCA) is a monogenic disease of high mortality, affecting millions of people worldwide. There is no broad, effective, and safe definitive treatment for SCA, so the palliative treatments are the most used. The establishment of an in vitro model allows better understanding of how the disease occurs, besides allowing the development of more effective tests and treatments. In this context, iPSC technology is a powerful tool for basic research and disease modeling, and a promise for finding and screening more effective and safe drugs, besides the possibility of use in regenerative medicine. This work obtained a model for study and treatment of SCA using iPSC. Then, episomal vectors were used for reprogramming peripheral blood mononuclear cells to obtain integration-free iPSC. Cells were collected from patients treated with hydroxyurea and without treatment. The iPSCP Bscd lines were characterized for pluripotent and differentiation potential. The iPSC lines were differentiated into HSC, so that we obtained a dynamic and efficient protocol of CD34+CD45+ cells production. We offer a valuable tool for a better understanding of how SCA occurs, in addition to making possible the development of more effective drugs and treatments and providing better understanding of widely used treatments, such as hydroxyurea.
ABSTRACT
BACKGROUND: The therapeutic use of human embryonic stem cells (hESCs) is dependent on an efficient cryopreservation protocol for long-term storage. The aim of this study was to determine whether the combination of three cryoprotecting reagents using two freezing systems might improve hESC recovery rates with maintenance of hESC pluripotency properties for potential cell therapy application. METHODS: Recovery rates of hESC colonies which were frozen in three cryoprotective solutions: Me2SO/HES/SR medium, Defined-medium® and Me2SO/SFB in medium solution were evaluated in ultra-slow programmable freezing system (USPF) and a slow-rate freezing system (SRF). The hESC pluripotency properties after freezing-thawing were evaluated. RESULTS: We estimated the distribution frequency of survival colonies and observed that independent of the freezing system used (USPF or SRF) the best results were obtained with Me2SO/HES/SR as cryopreservation medium. We showed a significant hESC recovery colonies rate after thawing in Me2SO/HES/SR medium were 3.88 and 2.9 in USPF and SRF, respectively. The recovery colonies rate with Defined-medium® were 1.05 and 1.07 however in classical Me2SO medium were 0.5 and 0.86 in USPF and SRF, respectively. We showed significant difference between Me2SO/HES/SR medium×Defined-medium® and between Me2SO/HES/SR medium×Me2SO medium, for two cryopreservation systems (P<0.05). CONCLUSION: We developed an in house protocol using the combination of Me2SO/HES/SR medium and ultra-slow programmable freezing system which resulted in hESC colonies that remain undifferentiated, maintain their in vitro and in vivo pluripotency properties and genetic stability. This approach may be suitable for cell therapy studies.
Subject(s)
Cryopreservation/methods , Dimethyl Sulfoxide/pharmacology , Human Embryonic Stem Cells/drug effects , Human Embryonic Stem Cells/physiology , Hydroxyethyl Starch Derivatives/pharmacology , Plasma Substitutes/pharmacology , Cell Survival/drug effects , Cell- and Tissue-Based Therapy/methods , Cryoprotective Agents/pharmacology , Culture Media, Serum-Free/pharmacology , Freezing , Human Embryonic Stem Cells/cytology , Humans , Pluripotent Stem Cells/cytologyABSTRACT
A epigenética compreende um conjunto de mecanismos que promovem a regulação da expressão gênica a nível transcricional através de modificações químicas no DNA e na cromatina, como metilação, acetilação e fosforilação, que resultam na conseqüente mudança fenotípica do indivíduo sem, no entanto, ocorrer nenhuma alteração na seqüência do DNA. Essas modificações químicas no DNA são constantemente feitas e desfeitas durante toda a vida do indivíduo, exceto para marcações químicas constitutivas que são herdadas geneticamente, visto que freqüentemente os indivíduos entram em contato com agentes promotores desses fenômenos durante a vida. Alterações nos padrões epigenéticos promovendo a expressão aberrante ou o silenciamento de determinados genes podem aparecer em organismos com idade avançada, e em uma ampla variedade de eventos e patologias como no câncer, na inativação do cromossomo X, no imprinting genômico, e em diversas síndromes de ordem neurológica e de prejuízo no desenvolvimento motor. Desse modo, busca-se atualmente o desenvolvimento de drogas que possuem a capacidade de reverter as marcações químicas alteradas em regiões específicas do genoma relacionadas a determinadas doenças. Uma maior compreensão desse universo da epigenética associada com suas implicações aos estados fisiológicos normais e patológicos mostra-se como uma grande promessa nessa era molecular, para o desenvolvimento de ferramentas profiláticas, diagnósticas e terapêuticas de uma ampla variedade de doenças.
Epigenetics includes several mechanisms that promote the gene expression regulation at transcriptional level through chemical changes in DNA and chromatin, such as methylation, acetylation and phosphorylation, resulting in phenotypic change without no changes occur in the DNA sequence. These DNA chemical changes are constantly made and unmade throughout the individual life, except for constitutive chemical markings that are genetically inherited, because often people are in contact with agents that promote these phenomens during their lifes. Changes in epigenetic patterns promoting aberrant expression or gene silencing may appear in aged organisms, and in a wide variety of events and conditions such as cancer, X chromosome inactivation in genomic imprinting, and in various neurological and motor development syndromes. Thus, seek currently drugs development that have the ability to reverse altered chemical markings in specific regions of the genome related to certain diseases. A greater understanding of the epigenetic universe associated with its implications to normal physiological and pathological states, it is a great promise in molecular era to development of prophylactic, diagnostic and therapeutic tools of a wide variety of diseases.
